Skip to main content

Table 1 State prevalence and transition probability matrix for anti-malarial treatments used before and during pregnancy

From: Is there a distinction between malaria treatment and intermittent preventive treatment? Insights from a cross-sectional study of anti-malarial drug use among Ugandan pregnant women

  State prevalences (%) n=330 Transition probabilities
  Before pregnancy During pregnancy → ACT/QNN → Others → SP
ACT/QNN → 74.5 41.9 0.451 0.085 0.463
Others → 12.1 7.9 0.425 0.025 0.550
SP → 13.3 51.2 0.159 0.091 0.750